Correlation Between Vigil Neuroscience and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Kymera Therapeutics, you can compare the effects of market volatilities on Vigil Neuroscience and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Kymera Therapeutics.
Diversification Opportunities for Vigil Neuroscience and Kymera Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Vigil and Kymera is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Kymera Therapeutics
Given the investment horizon of 90 days Vigil Neuroscience is expected to generate 1.17 times more return on investment than Kymera Therapeutics. However, Vigil Neuroscience is 1.17 times more volatile than Kymera Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 166.00 in Vigil Neuroscience on October 20, 2024 and sell it today you would earn a total of 27.00 from holding Vigil Neuroscience or generate 16.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vigil Neuroscience vs. Kymera Therapeutics
Performance |
| Timeline |
| Vigil Neuroscience |
| Kymera Therapeutics |
Vigil Neuroscience and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vigil Neuroscience and Kymera Therapeutics
The main advantage of trading using opposite Vigil Neuroscience and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |